Liang Chen
5PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 05, 2025
RBPMS inhibits bladder cancer metastasis by downregulating MYC pathway through alternative splicing of ANKRD10.Jingtian Yu, Liang Chen, Gang Wang
|Nov 09, 2024
Mevalonate pathway inhibition reduces bladder cancer metastasis by modulating RhoB protein stability and integrin β1 localization.Gang Wang, Tianchen Peng, Liang Chen
|Nov 26, 2023
Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation.Tao Liu, Wan Xiang, Zhizhuang Chen
|Dec 11, 2022
STIL Promotes Tumorigenesis of Bladder Cancer by Activating PI3K/AKT/mTOR Signaling Pathway and Targeting C-Myc.Hua Yu, Liang Chen, Xia Wang
|Aug 26, 2020
Immune-related signature predicts the prognosis and immunotherapy benefit in bladder cancer.Yejinpeng Wang, Liang Chen, Mengxue Yu
Pageof 1
